MetaCap

Alphatec Holdings Inc. (ATEC)

NASDAQ: ATECHealth CareMedical/Dental InstrumentsUSD

6.68-0.22 (-3.19%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ATEC stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$0.57
52-week range
6.63 – 23.29
Day range
6.63 – 7.00
Volume / Avg
3.05M / 3.38M
Beta
—

52-week range

$6.63$23.29

ATEC stock today

On Nov 20, ATEC ended the session at $6.68, shedding $0.22 (3.19%), versus the S&P 500's 3.70% decline. Shares are 71.3% below their 52-week high of $23.29, set on Jan 8, 2026 and 0.8% above the 52-week low of $6.63, near the bottom of the past year's range. ATEC is down 68.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 67.1%.

Alphatec has posted a net loss over the last twelve months (EPS of -$0.57), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Alphatec

Company profile

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.

Industry
Medical/Dental Instruments
CEO
Mr. Patrick S. Miles
Headquarters
Carlsbad, CA
Employees
913
IPO year
2006

Financial highlights

Full financials

In fiscal 2025, Alphatec generated $764.2 million in revenue, up 25.0% from fiscal 2024, its 7th consecutive year of revenue growth. Alphatec reported a net loss of $143.4 million, compared with a loss of $162.1 million a year earlier. Gross margin was 69.6% (up from 69.4%) and operating margin -10.7%.

Alphatec annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$764.15M$611.56M$482.26M$350.87M$243.21M
Growth+24.95%+26.81%+37.45%+44.26%+67.89%
Net income$-143.36M$-162.12M$-186.64M$-151.29M$-143.03M
EPS (diluted)$-0.96$-1.13$-1.54$-1.46$-1.49

Analyst forecast

Forecast

Consensus (14 analysts)

strong_buy

Avg. price target

$12.93+93.56%

  • Strong buy 3
  • Buy 9
  • Hold 2
  • Sell 0
  • Strong sell 0

Target range

Low $8.00High $24.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 29, 2026
EPS actual vs est.
$-0.03 vs $-0.07
Surprise
+57.14%

ATEC news

All ATEC news

Alphatec peers

Health Care sector
ATEC peer companies
CompanyPrice% ChgMarket capCompare
SGPSpyGlass Pharma Inc.30.43-1.14%$1.02Bvs ATEC
IARTIntegra LifeSciences Holdings Corporation13.25-2.21%$1.03Bvs ATEC
IRMDiRadimed Corporation81.02-0.30%$1.04Bvs ATEC
SIBNSI-BONE Inc.23.73-0.08%$1.07Bvs ATEC
DRTSAlpha Tau Medical Ltd.11.76+3.93%$1.09Bvs ATEC
AORTArtivion Inc.18.16-2.00%$886.02Mvs ATEC
TNDMTandem Diabetes Care Inc.17.46+3.93%$1.22Bvs ATEC
KIDSOrthoPediatrics Corp.31.74-2.37%$828.75Mvs ATEC

Indexes, lists and sector

Alphatec stock FAQ

What is Alphatec's stock price today?

ATEC last traded at $6.68 as of Nov 20, 4:00 PM EST, down 3.19% on the day. Prices are delayed at least 15 minutes.

Does Alphatec pay a dividend?

No. Alphatec does not currently pay a regular cash dividend.

Who is Alphatec's CEO?

Mr. Patrick S. Miles is the chief executive officer of Alphatec Holdings Inc., which has about 913 employees.

Has ATEC ever split its stock?

Yes. The most recent ATEC stock split was a 1-for-12 split on Aug 25, 2016.

What is the ATEC 52-week high?

The 52-week high for ATEC is $23.29 and the 52-week low is $6.63. The stock is currently 71.3% below its high.

Compare ATEC